Citadel Advisors - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$1,703,309
+45.9%
337,289
+45.3%
0.00%
Q2 2023$1,167,720
-42.5%
232,151
-29.7%
0.00%
Q1 2023$2,030,773
-67.9%
330,207
-31.0%
0.00%
-100.0%
Q4 2022$6,320,530
+332.3%
478,828
-2.8%
0.00%
Q3 2022$1,462,000
-25.3%
492,523
-8.1%
0.00%
Q2 2022$1,956,000
-11.7%
536,017
+49.9%
0.00%
Q1 2022$2,214,000
+36.2%
357,678
+78.2%
0.00%
Q4 2021$1,625,000
-66.6%
200,682
-38.5%
0.00%
-100.0%
Q3 2021$4,862,000
+62.2%
326,247
+36.6%
0.00%
Q2 2021$2,998,000238,9140.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q1 2022
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders